Woodline Partners LP Ascendis Pharma A/S Transaction History

Woodline Partners LP

$11 Billion
Q3 2024

A detailed history of Woodline Partners LP transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Woodline Partners LP holds 235,018 shares of ASND stock, worth $32.1 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

235,018

Previous 198,766 18.24%

Holding current value

$32.1 Million

Previous $27.1 Million 29.48%

% of portfolio

0.32%

Previous 0.27%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$113.0 - $153.43 $4.1 Million - $5.56 Million	36,252 Added 18.24%	235,018 $35.1 Million
Q2 2024 Aug 14, 2024	BUY	$121.07 - $153.67 $331,247 - $420,441	2,736 Added 1.4%	198,766 $27.1 Million
Q1 2024 May 15, 2024	BUY	$123.45 - $159.4 $22.2 Million - $28.7 Million	179,881 Added 1113.88%	196,030 $29.6 Million
Q4 2023 Feb 14, 2024	BUY	$86.1 - $127.36 $1.39 Million - $2.06 Million	16,149 New	16,149 $2.03 Million
Q1 2023 May 15, 2023	BUY	$104.9 - $126.78 $22 Million - $26.6 Million	209,683 Added 220.46%	304,796 $32.7 Million
Q4 2022 Feb 14, 2023	SELL	$99.42 - $131.97 $11.6 Million - $15.3 Million	-116,280 Reduced 55.01%	95,113 $11.6 Million
Q3 2022 Nov 14, 2022	BUY	$84.03 - $110.23 $8.85 Million - $11.6 Million	105,267 Added 99.19%	211,393 $21.8 Million
Q2 2022 Aug 15, 2022	SELL	$78.08 - $117.61 $459,578 - $692,252	-5,886 Reduced 5.25%	106,126 $9.87 Million
Q1 2022 May 16, 2022	SELL	$102.18 - $135.75 $11.5 Million - $15.3 Million	-112,437 Reduced 50.09%	112,012 $13.1 Million
Q4 2021 Feb 14, 2022	BUY	$127.1 - $169.66 $28.5 Million - $38.1 Million	224,449 New	224,449 $30.2 Million
Q1 2020 May 15, 2020	SELL	$97.01 - $145.11 $5.36 Million - $8.02 Million	-55,284 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$91.45 - $139.12 $5.06 Million - $7.69 Million	55,284 New	55,284 $7.69 Million

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Ascendis Pharma A/S Transaction History